What is it?
For cats with anemia due to chronic kidney disease. This is a serious, progressive condition with no FDA-approved treatments
Cats with CKD can receive free screenings for anemia. Enrolled cats receive the treatment as well as related exams and lab tests for free
Fully funded FDA-regulated clinical study
Monitoring includes multiple physical exams and lab tests
Involves a single injection followed by 70 days of monitoring. One injection may relieve anemia for the cat’s lifetime
Owners that comply with study requirements may be compensated for their time
About the therapy in development
Scout is developing a new kind of therapy for pets. It uses a technique approved in humans called AAV vector-mediated gene transfer. The therapy being investigated in this study is designed to address feline anemia by increasing the levels of a certain protein, EPO, in a cat. EPO encourages a cat’s body to make more red blood cells to relieve anemia and improve oxygen carrying capacity.
Scout has already shown that this investigational therapy leads to sustained and statistically significant increases in the red blood cell counts in cats. These data have supported starting the large clinical study now underway.Learn more about Scout Bio
What is anemia associated with chronic kidney disease?
Anemia results in low oxygen in the blood due to a lower number of oxygen-carrying red blood cells. It can be caused by various conditions, but in the case of CKD, ongoing kidney damage reduces production of a protein called erythropoietin (EPO), which is required for normal development of red blood cells.
CKD may affect younger cats, but is associated with aging. Approximately 7.5% of cats above age 10 have CKD, and incidence increases with age.
CKD-associated anemia leads to a progressive deterioration in quality-of-life with a variety of symptoms including weight loss, fatigue, weakness, fainting, and seizures.